Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small spot of blood at the injection site after a Mounjaro dose is common and usually nothing to worry about. It happens because the needle occasionally nicks a tiny capillary just beneath the skin. Most people see nothing more than a pinprick; a few get a small bruise that fades within a few days. Mounjaro is a prescription-only medicine, and any concerns about your injection technique or site reactions should be discussed with your prescriber. Mounjaro (tirzepatide) is administered as a once-weekly subcutaneous injection, and minor bleeding is one of the most frequently reported injection-site events across the clinical programme.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The skin and the fat layer beneath it are threaded with tiny capillaries. A subcutaneous needle, even one as fine as the pen needle used with Mounjaro, can clip one of these vessels on its way in or out. The result is a small bleed that surfaces as a drop of blood at the injection point, sometimes as a bruise that appears over the next hour or two.
This is a mechanical event, not a sign that the medicine has gone somewhere it shouldn't. Tirzepatide is designed for the subcutaneous fat layer, and the needle is short enough that it does not reach muscle in most injection sites. A drop of blood at the surface tells you the needle has exited cleanly; it says nothing about where the medicine was deposited.
The KwikPen's post-injection window is worth checking here: holding the pen against the skin for the full count after the dose is released gives the medicine time to disperse before withdrawal, which also reduces the chance of a drag bleed as the needle pulls back.
Most bleeds stop on their own within a minute. Press a dry piece of cotton wool or a clean fingertip to the spot, hold it still without rubbing, and that is usually enough.
A single drop of blood or a small pink smear on your clothing: normal. A bruise up to roughly the size of a 50p coin appearing over the next day: common, especially if you injected near a visible surface vein or in an area of thinner fat. Mild tenderness around the site for 24–48 hours: unremarkable.
What sits outside that range is worth noting and potentially acting on. A bleed that does not stop within five minutes of firm pressure, a bruise that spreads noticeably over several hours, or a site that becomes warm, swollen, and painful rather than just tender: these deserve a call to your prescriber. They may indicate a vessel of more than capillary size was nicked, or that something else is happening at the tissue level.
A hard lump under the skin appearing after a bleed can be a haematoma, a small pool of blood collecting in the tissue. These usually resolve without treatment but can take a couple of weeks and are occasionally uncomfortable. Cold compresses help with early swelling; if the lump grows or becomes very painful, speak to your prescriber.
If you take blood-thinning medication such as warfarin or apixaban, minor bleeds can be more pronounced. Tell your prescriber before starting Mounjaro, and mention any medication changes afterwards. They can advise whether any additional monitoring of your injection technique is sensible.
Most repeat bleeds trace back to two things: not rotating sites, and injection angle. Injecting into the same small patch every week allows tissue trauma to accumulate, which makes capillary damage more likely next time. The guidance is to move around the available area on the abdomen, thigh, or upper arm, and to keep each injection at least a couple of centimetres away from the previous spot.
Pinching the skin gently before inserting the needle lifts a fold of fat clear of the underlying muscle and steadies the target zone. Inserting the needle at a 90-degree angle to that pinched fold is the standard approach for most people; very lean individuals may benefit from a 45-degree angle to stay within the fat layer. Your Patient Information Leaflet and the NHS tirzepatide guidance cover this in more detail.
If bleeding is a recurring pattern rather than an occasional event, it is also worth checking whether you are using a fresh needle each time. Blunt or bent tips cause more tissue trauma. Replacement pen needles are inexpensive, and a new one for every injection is standard practice.
Cleaning the site beforehand with an alcohol swab and letting it dry fully before injecting is also worth noting. It is equally sensible to think about timing around meals, and our guide to whether you can inject Mounjaro after food explains how eating before your dose can affect comfort at the site. Injecting through wet skin can sting more and may introduce surface bacteria, though it does not in itself cause bleeding.
For the vast majority of people, blood after a Mounjaro injection is a two-minute inconvenience. But some signs call for prompt attention. Seek medical help if you notice a bleed that will not stop with pressure, a rapidly expanding bruise, significant swelling or redness spreading away from the site, fever, or skin that feels hot to touch. These may point to an infection or a deeper vessel injury that needs assessment.
Any injection-site reaction that is getting worse rather than better after 48 hours is worth flagging. A rash at or around the injection site is a separate issue and should also be reviewed, since it can sometimes indicate a local allergic response.
You can report unexpected side effects, including unusual injection-site reactions, through the MHRA's Yellow Card scheme, which helps regulators track patterns across the population using these medicines. It takes a few minutes and genuinely contributes to the evidence base.
If you have ongoing questions about your injection technique or are new to Mounjaro and want guidance tailored to your situation, the prescribers at our clinical team are available seven days a week, and reading up on the best food to eat after your Mounjaro injection can also help you manage post-dose comfort alongside any site reactions. Start your free consultation to speak with a GPhC-registered prescriber who can review your circumstances properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.